Dr. Daly, the Chair of the Department of Clinical Genetics at Fox Chase Cancer Center, is an epidemiologist and medical oncologist with a special interest in cancer prevention and control. In 1991, she founded the Risk Assessment Program (RAP) to offer patients with cancer and their family members education and information about cancer risk, screening, diagnosis, and treatment with an emphasis on the genetic contribution to cancer risk. RAP serves as a research recruitment base for the ongoing evaluation of epidemiological, biologic, genetic, and environmental lifestyle factors that influence susceptibility to cancer, thus providing a unique opportunity to explore risk-reducing interventions. The program places great emphasis on defining the best methods of communicating cancer risk information and on providing risk management strategies and coping skills to family members dealing with an increased risk for cancer. The ideas and viewpoints expressed in this editorial are those of the author and do not necessarily represent any policy, position, or program of NCCN.